Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow-2.84 M USD-11.01 M USD-12.89 M USD-7.52 M USD-8.60 M USD-3.43 M USD-5.40 M USD-21106 USD-45151 USD-26173 USD
Depreciation & Amortization261679 USD246791 USD199266 USD118620 USD80748 USD47609 USD27569 USD
Stock-Based Compensation1.26 M USD1.34 M USD1.11 M USD947212 USD324205 USD
Capital Expenditures81742 USD120197 USD384117 USD275226 USD67079 USD122427 USD58352 USD
Cash Flow from Investing-81742 USD-120197 USD2.65 M USD-3.24 M USD-67079 USD-122427 USD-123352 USD0 USD0 USD0 USD
Cash Flow from Financing8.03 M USD7.27 M USD7.40 M USD12.02 M USD11.53 M USD7.32 M USD5.77 M USD21106 USD46784 USD25853 USD
Dividends Paid
Stock Buybacks-124617 USD-81403 USD-119419 USD0 USD
Free Cash Flow-2.92 M USD-11.13 M USD-13.27 M USD-7.79 M USD-8.67 M USD-3.55 M USD-5.45 M USD

NeuroOne Medical Technologies Corporation is a medical technology company that develops and markets cutting-edge neural surgical solutions. The company's primary focus lies in designing advanced electrode technology for recording and stimulating brain activity, which plays a crucial role in diagnosing and treating various neurological disorders. These electrodes are used for electroencephalography (EEG), electrocorticography (ECoG), and brain stimulation therapies, impacting sectors such as neurology, neurosurgery, and neurodiagnostics. NeuroOne's innovative products aim to address unmet needs in the medical field by providing less invasive and more cost-effective solutions for brain surgeries and therapeutic treatments. Headquartered in the United States, NeuroOne Medical Technologies Corporation is at the forefront of enhancing the capabilities of neural procedures and treatments, potentially transforming how healthcare providers approach neurological conditions.